Biopharmaceutical Analysis

Roche’s Digital LightCycler System is designed to aid in diagnostics for cancer, genetic disease, and infection.

A holistic view of the product, manufacturing, and ultimate use of the viral vector is required.

It is important to understand regulatory requirements and study challenges to develop and validate the appropriate methods for a bioanalytical study program at the clinical stage.

CYTENA’s B.SIGHT cell dispenser is designed to streamline single-cell isolation in microbiology research.

The Faustovirus Capping Enzyme launched by New England Biolabs is designed to increase capping efficiency and scalability of mRNA manufacturing workflows.

Guest contributor B.S. Sathya Durga discusses the importance of modernizing India's pharmaceutical manufacturing industry.

Preclinical testing is better able to evaluate complex drug candidates thanks to innovations in animal model approaches.

Synthego has launched new engineered cell libraries to validate targets for quicker drug discovery timelines.

A strong digital backbone is foundational in driving innovation.

Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis.

Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.

The PerkinElmer Flow Cytometry Instrument Concierge Services will provide biopharmaceutical labs with expert, on-site flow cytometry specialists.

Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.

Bio-Rad’s CFX Opus Deepwell Real-Time PCR Detection System is designed to support researchers in developing nucleic acid detection assays.

Bio-Rad’s EconoFit Chromatography Column Packs support resin screening experiments in the development of protein purification workflows.

The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.

By understanding potential material change, the impact on patient safety can be understood and mitigated.

Systemic inefficiencies in the pharmaceutical industry undermine problem-solving efforts.

Inceptor Bio and the University of Minnesota aim to build a novel iPSC platform to accelerate cell therapy drug development.

Aizon Digitize is designed to help life science manufacturers transition data from paper to digital.

Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites.

Axol Bioscience’s CiPA-validated ventricular cardiomyocytes can be used as a robust cardiotoxicity measurement tool.

One get obtain a clearer assessment of gene-editing outcomes through more exacting analytical tools.

One can use modeling methods to generate data and shorten development timelines in preclinical studies.

BioRad Laboratories CFX Duet System is designed to help researchers develop singleplex and duplex quantitative polymerase chain reaction assays.

Linking structure with function is paramount.

When considering whether to outsource work to a CRO, there are a number of factors to assess, including the type of work that may be outsourced, regulatory considerations, and needs for the study.

Through the Thermo Fisher Scientific and LabShares Newton partnership, life science startups can accelerate early-stage discovery and development with shared lab spaces.

PerkinElmer has expanded its genomics testing services with the launch of its ultrarapid whole genome sequencing.

908 Devices and CPI have formed a collaboration to optimize cell culture media to allow for improved process control.